Torno Capital »

Crispr Therapeutics shares owned by Torno Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Torno Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 45k 68.16
2023-12-31 $645k 10k 62.60

More positions owned by Torno Capital

Alphabet Cap Stk Cl A Put Option (GOOGL)
Caterpillar Put Option (CAT)
Booking Holdings Put Option (BKNG)
Microsoft Corporation Put Option (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
MercadoLibre Put Option (MELI)
Ulta Salon, Cosmetics & Fragrance Put Option (ULTA)
Dollar Tree Call Option (DLTR)
Cadence Design Systems Put Option (CDNS)
Regeneron Pharmaceuticals Put Option (REGN)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Ge Healthcare Technologies I Common Stock Put Option (GEHC)
Exxon Mobil Corporation Call Option (XOM)
Cheniere Energy Com New Call Option (LNG)
Super Micro Computer Put Option (SMCI)

View all positions for Torno Capital

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Morgan Stanley
Bank of America Corporation
Loomis, Sayles and
Dimensional Fund Advisors

View all funds holding Crispr Therapeutics